发明申请
US20060058304A1 Azaindole kinase inhibitors 审中-公开
Azaindole激酶抑制剂

Azaindole kinase inhibitors
摘要:
The present invention provides compounds of formula I, and pharmaceutically acceptable salts thereof. The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2 and FGFR-1, thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
信息查询
0/0